The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cell Perfusion Systems Market Research Report 2025
Synopsis
Perfusion cell culture utilizes a cell retention device and continuous media exchange to achieve and maintain high cell densities and viabilities over extended periods of time.
Global Cell Perfusion Systems market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cell Perfusion Systems market research.
Key manufacturers engaged in the Cell Perfusion Systems industry include Repligen, Fluigent, ibidi, Cytiva, Spectrum Medical, Elveflow, Precigenome, Merck KGaA and Harvard Apparatus, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
For production bases, global Cell Perfusion Systems production is dominated by and . The two regions contributed to % production share globally in 2022.
When refers to consumption region, % volume of Cell Perfusion Systems were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cell Perfusion Systems market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cell Perfusion Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Repligen
Fluigent
ibidi
Cytiva
Spectrum Medical
Elveflow
Precigenome
Merck KGaA
Harvard Apparatus
Sartorius Stedim Biotech
AutoMate Scientific
REPROCELL
Tokai HIT
Biophysical Tools
3D Biotek
TA Instruments
Takasago Electric
Segment by Type
Recirculating Systems
Non-Recirculating Systems
Segment by Application
Drug Development
Disease Modeling
Personalized Medicine
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Cell Perfusion Systems report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Perfusion cell culture utilizes a cell retention device and continuous media exchange to achieve and maintain high cell densities and viabilities over extended periods of time.
Global Cell Perfusion Systems market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cell Perfusion Systems market research.
Key manufacturers engaged in the Cell Perfusion Systems industry include Repligen, Fluigent, ibidi, Cytiva, Spectrum Medical, Elveflow, Precigenome, Merck KGaA and Harvard Apparatus, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
For production bases, global Cell Perfusion Systems production is dominated by and . The two regions contributed to % production share globally in 2022.
When refers to consumption region, % volume of Cell Perfusion Systems were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cell Perfusion Systems market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cell Perfusion Systems market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Repligen
Fluigent
ibidi
Cytiva
Spectrum Medical
Elveflow
Precigenome
Merck KGaA
Harvard Apparatus
Sartorius Stedim Biotech
AutoMate Scientific
REPROCELL
Tokai HIT
Biophysical Tools
3D Biotek
TA Instruments
Takasago Electric
Segment by Type
Recirculating Systems
Non-Recirculating Systems
Segment by Application
Drug Development
Disease Modeling
Personalized Medicine
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Cell Perfusion Systems report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Index1 Cell Perfusion Systems Market Overview
1.1 Product Definition
1.2 Cell Perfusion Systems Segment by Type
1.2.1 Global Cell Perfusion Systems Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Recirculating Systems
1.2.3 Non-Recirculating Systems
1.3 Cell Perfusion Systems Segment by Application
1.3.1 Global Cell Perfusion Systems Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Drug Development
1.3.3 Disease Modeling
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Cell Perfusion Systems Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Cell Perfusion Systems Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Cell Perfusion Systems Production Estimates and Forecasts (2018-2029)
1.4.4 Global Cell Perfusion Systems Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Cell Perfusion Systems Production Market Share by Manufacturers (2018-2023)
2.2 Global Cell Perfusion Systems Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Cell Perfusion Systems, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Cell Perfusion Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Cell Perfusion Systems Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Cell Perfusion Systems, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Cell Perfusion Systems, Product Offered and Application
2.8 Global Key Manufacturers of Cell Perfusion Systems, Date of Enter into This Industry
2.9 Cell Perfusion Systems Market Competitive Situation and Trends
2.9.1 Cell Perfusion Systems Market Concentration Rate
2.9.2 Global 5 and 10 Largest Cell Perfusion Systems Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Cell Perfusion Systems Production by Region
3.1 Global Cell Perfusion Systems Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Cell Perfusion Systems Production Value by Region (2018-2029)
3.2.1 Global Cell Perfusion Systems Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Cell Perfusion Systems by Region (2024-2029)
3.3 Global Cell Perfusion Systems Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Cell Perfusion Systems Production by Region (2018-2029)
3.4.1 Global Cell Perfusion Systems Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Cell Perfusion Systems by Region (2024-2029)
3.5 Global Cell Perfusion Systems Market Price Analysis by Region (2018-2023)
3.6 Global Cell Perfusion Systems Production and Value, Year-over-Year Growth
3.6.1 North America Cell Perfusion Systems Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Cell Perfusion Systems Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Cell Perfusion Systems Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Cell Perfusion Systems Production Value Estimates and Forecasts (2018-2029)
4 Cell Perfusion Systems Consumption by Region
4.1 Global Cell Perfusion Systems Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Cell Perfusion Systems Consumption by Region (2018-2029)
4.2.1 Global Cell Perfusion Systems Consumption by Region (2018-2023)
4.2.2 Global Cell Perfusion Systems Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Cell Perfusion Systems Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Cell Perfusion Systems Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Cell Perfusion Systems Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Cell Perfusion Systems Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Cell Perfusion Systems Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Cell Perfusion Systems Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Cell Perfusion Systems Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Cell Perfusion Systems Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Cell Perfusion Systems Production by Type (2018-2029)
5.1.1 Global Cell Perfusion Systems Production by Type (2018-2023)
5.1.2 Global Cell Perfusion Systems Production by Type (2024-2029)
5.1.3 Global Cell Perfusion Systems Production Market Share by Type (2018-2029)
5.2 Global Cell Perfusion Systems Production Value by Type (2018-2029)
5.2.1 Global Cell Perfusion Systems Production Value by Type (2018-2023)
5.2.2 Global Cell Perfusion Systems Production Value by Type (2024-2029)
5.2.3 Global Cell Perfusion Systems Production Value Market Share by Type (2018-2029)
5.3 Global Cell Perfusion Systems Price by Type (2018-2029)
6 Segment by Application
6.1 Global Cell Perfusion Systems Production by Application (2018-2029)
6.1.1 Global Cell Perfusion Systems Production by Application (2018-2023)
6.1.2 Global Cell Perfusion Systems Production by Application (2024-2029)
6.1.3 Global Cell Perfusion Systems Production Market Share by Application (2018-2029)
6.2 Global Cell Perfusion Systems Production Value by Application (2018-2029)
6.2.1 Global Cell Perfusion Systems Production Value by Application (2018-2023)
6.2.2 Global Cell Perfusion Systems Production Value by Application (2024-2029)
6.2.3 Global Cell Perfusion Systems Production Value Market Share by Application (2018-2029)
6.3 Global Cell Perfusion Systems Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Repligen
7.1.1 Repligen Cell Perfusion Systems Corporation Information
7.1.2 Repligen Cell Perfusion Systems Product Portfolio
7.1.3 Repligen Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Repligen Main Business and Markets Served
7.1.5 Repligen Recent Developments/Updates
7.2 Fluigent
7.2.1 Fluigent Cell Perfusion Systems Corporation Information
7.2.2 Fluigent Cell Perfusion Systems Product Portfolio
7.2.3 Fluigent Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Fluigent Main Business and Markets Served
7.2.5 Fluigent Recent Developments/Updates
7.3 ibidi
7.3.1 ibidi Cell Perfusion Systems Corporation Information
7.3.2 ibidi Cell Perfusion Systems Product Portfolio
7.3.3 ibidi Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.3.4 ibidi Main Business and Markets Served
7.3.5 ibidi Recent Developments/Updates
7.4 Cytiva
7.4.1 Cytiva Cell Perfusion Systems Corporation Information
7.4.2 Cytiva Cell Perfusion Systems Product Portfolio
7.4.3 Cytiva Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Cytiva Main Business and Markets Served
7.4.5 Cytiva Recent Developments/Updates
7.5 Spectrum Medical
7.5.1 Spectrum Medical Cell Perfusion Systems Corporation Information
7.5.2 Spectrum Medical Cell Perfusion Systems Product Portfolio
7.5.3 Spectrum Medical Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Spectrum Medical Main Business and Markets Served
7.5.5 Spectrum Medical Recent Developments/Updates
7.6 Elveflow
7.6.1 Elveflow Cell Perfusion Systems Corporation Information
7.6.2 Elveflow Cell Perfusion Systems Product Portfolio
7.6.3 Elveflow Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Elveflow Main Business and Markets Served
7.6.5 Elveflow Recent Developments/Updates
7.7 Precigenome
7.7.1 Precigenome Cell Perfusion Systems Corporation Information
7.7.2 Precigenome Cell Perfusion Systems Product Portfolio
7.7.3 Precigenome Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Precigenome Main Business and Markets Served
7.7.5 Precigenome Recent Developments/Updates
7.8 Merck KGaA
7.8.1 Merck KGaA Cell Perfusion Systems Corporation Information
7.8.2 Merck KGaA Cell Perfusion Systems Product Portfolio
7.8.3 Merck KGaA Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Merck KGaA Main Business and Markets Served
7.7.5 Merck KGaA Recent Developments/Updates
7.9 Harvard Apparatus
7.9.1 Harvard Apparatus Cell Perfusion Systems Corporation Information
7.9.2 Harvard Apparatus Cell Perfusion Systems Product Portfolio
7.9.3 Harvard Apparatus Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Harvard Apparatus Main Business and Markets Served
7.9.5 Harvard Apparatus Recent Developments/Updates
7.10 Sartorius Stedim Biotech
7.10.1 Sartorius Stedim Biotech Cell Perfusion Systems Corporation Information
7.10.2 Sartorius Stedim Biotech Cell Perfusion Systems Product Portfolio
7.10.3 Sartorius Stedim Biotech Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Sartorius Stedim Biotech Main Business and Markets Served
7.10.5 Sartorius Stedim Biotech Recent Developments/Updates
7.11 AutoMate Scientific
7.11.1 AutoMate Scientific Cell Perfusion Systems Corporation Information
7.11.2 AutoMate Scientific Cell Perfusion Systems Product Portfolio
7.11.3 AutoMate Scientific Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.11.4 AutoMate Scientific Main Business and Markets Served
7.11.5 AutoMate Scientific Recent Developments/Updates
7.12 REPROCELL
7.12.1 REPROCELL Cell Perfusion Systems Corporation Information
7.12.2 REPROCELL Cell Perfusion Systems Product Portfolio
7.12.3 REPROCELL Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.12.4 REPROCELL Main Business and Markets Served
7.12.5 REPROCELL Recent Developments/Updates
7.13 Tokai HIT
7.13.1 Tokai HIT Cell Perfusion Systems Corporation Information
7.13.2 Tokai HIT Cell Perfusion Systems Product Portfolio
7.13.3 Tokai HIT Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Tokai HIT Main Business and Markets Served
7.13.5 Tokai HIT Recent Developments/Updates
7.14 Biophysical Tools
7.14.1 Biophysical Tools Cell Perfusion Systems Corporation Information
7.14.2 Biophysical Tools Cell Perfusion Systems Product Portfolio
7.14.3 Biophysical Tools Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Biophysical Tools Main Business and Markets Served
7.14.5 Biophysical Tools Recent Developments/Updates
7.15 3D Biotek
7.15.1 3D Biotek Cell Perfusion Systems Corporation Information
7.15.2 3D Biotek Cell Perfusion Systems Product Portfolio
7.15.3 3D Biotek Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.15.4 3D Biotek Main Business and Markets Served
7.15.5 3D Biotek Recent Developments/Updates
7.16 TA Instruments
7.16.1 TA Instruments Cell Perfusion Systems Corporation Information
7.16.2 TA Instruments Cell Perfusion Systems Product Portfolio
7.16.3 TA Instruments Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.16.4 TA Instruments Main Business and Markets Served
7.16.5 TA Instruments Recent Developments/Updates
7.17 Takasago Electric
7.17.1 Takasago Electric Cell Perfusion Systems Corporation Information
7.17.2 Takasago Electric Cell Perfusion Systems Product Portfolio
7.17.3 Takasago Electric Cell Perfusion Systems Production, Value, Price and Gross Margin (2018-2023)
7.17.4 Takasago Electric Main Business and Markets Served
7.17.5 Takasago Electric Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Cell Perfusion Systems Industry Chain Analysis
8.2 Cell Perfusion Systems Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Cell Perfusion Systems Production Mode & Process
8.4 Cell Perfusion Systems Sales and Marketing
8.4.1 Cell Perfusion Systems Sales Channels
8.4.2 Cell Perfusion Systems Distributors
8.5 Cell Perfusion Systems Customers
9 Cell Perfusion Systems Market Dynamics
9.1 Cell Perfusion Systems Industry Trends
9.2 Cell Perfusion Systems Market Drivers
9.3 Cell Perfusion Systems Market Challenges
9.4 Cell Perfusion Systems Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Industrial Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
